SKLB-329 is a multikinase inhibitor which potently inhibits angiogenesis-related kinases including VEGFR1/2/3, FGFR2, and the Src kinase. SKLB-329 was preclinically evaluated as a therapeutic agent against hepatocellular carcinoma.
MedKoo Cat#: 565418
Name: SKLB-329
CAS#: NONE
Chemical Formula: C19H11ClF4N6O2
Exact Mass: 466.0568
Molecular Weight: 466.78
Elemental Analysis: C, 48.89; H, 2.38; Cl, 7.59; F, 16.28; N, 18.00; O, 6.86
The following data is based on the product molecular weight 466.78 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
